Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ClinicalTrials.gov Is “Right Place” To List All Trials, NIH Says

This article was originally published in The Gray Sheet

Executive Summary

The National Library of Medicine is ready to expand ClinicalTrials.gov to include all clinical trials once they begin, NLM Director Donald Lindberg, MD, recently told the agency's Board of Regents

You may also be interested in...



Trial Rethink: New Medical Journal Paradigm Should Factor Into Study Plans

Firms may need to become more selective in deciding which trials to conduct if a barrage of negative results are to be avoided, Robert Klepinski, president of Klepinski and DuVal, advised during a recent Regulatory Affairs Professionals Society meeting in Washington, D.

Trial Rethink: New Medical Journal Paradigm Should Factor Into Study Plans

Firms may need to become more selective in deciding which trials to conduct if a barrage of negative results are to be avoided, Robert Klepinski, president of Klepinski and DuVal, advised during a recent Regulatory Affairs Professionals Society meeting in Washington, D.

Medical Journals To Require Registration Of Devices On ClinicalTrials.Gov

Medical device firms as well as pharmaceutical companies will be required to register their clinical trials in a public registry as a prerequisite of journal publication, according to New England Journal of Medicine Executive Editor Gregory Curfman, MD

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel